Neonatal porcine sertoli cells inhibit human natural antibody-mediated lysis

Biology of Reproduction

Volumn 72, Issue 5, 2005, Pages 1224-1231

  Dufour, Jannette M ^a   Hamilton, Meredith ^a   Rajotte, Ray V ^a   Korbutt, Gregory S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Immunology; Male reproductive tract; Sertoli cells; Testis

Indexed keywords

CARBOHYDRATE ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL CELL; ANIMAL CELL CULTURE; AORTA; ARTICLE; BLOOD GROUP AB; CELL DEATH; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTER; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SERTOLI CELL;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, HETEROPHILE; ANTIGENS, HETEROPHILE; COMPLEMENT ACTIVATION; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; IMMUNITY, NATURAL; MALE; SERTOLI CELLS; SUS SCROFA; TRISACCHARIDES;

MYCOBACTERIUM AVIUM COMPLEX (MAC); RODENTIA; SUIDAE;

EID: 17444396691     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.104.038315     Document Type: Article

References (54)

1. Platt JL. A primer in xenotransplantation. In: Platt JL (ed.), Xenotransplantation. Washington: ASM Press; 2001:3-28.
2. Galili U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14:480-482.
3. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IFC. Anti-pig IgM antibodies in human serum react predominantly with Gal(α1-3)Gal epitopes. Proc Natl Acad Sci U S A 1993; 90:11391-11395.
4. Cooper DKC, Good AH, Koren E, Oriol R, Malcolm AJ, Ippolito RM, Neethling FA, Ye Y, Romano E, Zuhdi N. Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol 1993; 1:198-205.
5. Vaughan HA, Loveland BE, Sandrin MS. Gal(α1-3)Gal is the major xenoepitope expressed on pig endothelial cells recognized by naturally occurring cytotoxic human antibodies. Transplantation 1994; 58:879-882.
6. Oriol R, Ye Y, Koren E, Cooper DKC. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56:1433-1442.
7. McKenzie IFC, Xing PX, Vaughan HA, Prenzoska J, Dabkowski PL, Sandrin MS. Distribution of the major xenoantigen (gal(α1-3)gal) for pig-to-human xenografts. Transpl Immunol 1994; 2:81-86.
8. Dor FJMF, Cheng J, Alt A, Cooper DKC, Schuurman HJ. Galα1,3Gal expression on porcine pancreatic islets, testis, spleen, and thymus. Xenotransplantation 2004; 11:101-106.
9. Cameron DF, Whittington K, Schultz RE, Selawry HP. Successful islet/abdominal testis transplantation does not require Leydig cells. Transplantation 1990; 50:649-653.
10. Whitmore WF III, Karsh L, Gittes RF. The role of germinal epithelium and spermatogenesis in the privileged survival of intratesticular grafts. J Urol 1985; 134:782-786.
11. Korbutt GS, Elliott JF, Rajotte RV. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 1997; 46:317-322.
12. Selawry HP, Cameron DF. Sertoli cell-enriched fractions in successful islet cell transplantation. Cell Transplant 1993; 2:123-129.
13. Yang H, Wright JR Jr. Co-encapsulation of Sertoli enriched testicular cell fractions further prolongs fish-to-mouse islet xenograft survival. Transplantation 1999; 67:815-820.
14. Dufour JM, Rajotte RV, Kin T, Korbutt GS. Immunoprotection of rat islet xenografts by cotransplantation with Sertoli cells and a single injection of antilymphocyte serum. Transplantation 2003; 75:1594-1596.
15. Korbutt GS, Suarez-Pinzon WL, Power RF, Rajotte RV, Rabinovitch A. Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice. Diabetologia 2000; 43:474-480.
16. Suarez-Pinzon W, Korbutt GS, Power R, Hooton J, Rajotte RV, Rabinovitch A. Testicular Sertoli cells protect islet β-cells from autoimmune destruction in NOD mice by a transforming growth factor β1-dependent mechanism. Diabetes 2000; 49:1810-1818.
17. Sanberg PR, Borlongan CV, Saporta S, Cameron DF. Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain. Nat Biotechnol 1996; 14:1692-1695.
18. Dufour JM, Rajotte RV, Seeberger K, Kin T, Korbutt GS. Long-term survival of neonatal porcine Sertoli cells in non-immunosuppressed rats. Xennotransplantation 2003; 10:577-586.
19. Gores PF, Hayes DH, Copeland MJ, Korbutt GS, Halberstadt C, Kirkpatrick SA, Rajotte RV. Long-term survival of intra-testicular porcine islets in non-immunosuppressed beagles. Transplantation 2003; 75:613-618.
20. Korbutt GS, Aspeslet LJ, Rajotte RV, Warnock GL, Ao Z, Ezekowitz J, Malcolm AJ, Koshal A, Yatscoff RW. Natural human antibody-mediated destruction of porcine neonatal islet cell grafts. Xenotransplantation 1996; 3:207-216.
21. Rayat GR, Rajotte RV, Elliot JF, Korbutt GS. Expression of Galα(1,3)Gal on neonatal porcine islet β-cells and susceptibility to human antibody/complement lysis. Diabetes 1998; 47:1406-1411.
22. Dufour JM, Rajotte RV, Korbutt GS. Development of an in vivo model to study testicular morphogenesis. J Androl 2002; 23:635-644.
23. Hayes CE, Goldstein IJ. An α-D-galactosyl-binding lectin from Bandeiraea simplicifolia seeds. Isolation by affinity chromatography and characterization. J Biol Chem 1974; 249:1904-1914.
24. Wood C, Kabat EA, Murphy LA, Goldstein IJ. Immunochemical studies of the combining sites of the two isolectins A4 and B4, isolated from Bandeiraea simplicifolia. Arch Biochem Biophys 1979; 198:1-11.
25. Zhoa Z, Termignon JL, Cardoso J, Chereau C, Gautreau C, Calmus Y, Houssin D, Weill B. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. Transplantation 1994; 57:245-249.
26. Dalmasso AP, Vercellotti GM, Fischel RJ, Bolman RM, Bach FH, Platt JL. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992; 140:1157-1166.
27. Skinner MK. Secretion of growth factors and other regulatory factors. In: Russell LD, Griswold MD (eds.), The Sertoli Cell. Clearwater, FL: Cache River Press; 1993:237-247.
28. Cupp AS, Kim GH, Skinner MK. Expression and action of neurotropin-3 and nerve growth factor in embryonic and early postnatal rat testis development. Biol Reprod 2000; 63:1617-1628.
29. Cupp AS, Dufour JM, Kim G, Skinner MK, Kim KH. Actions of retinoids on embryonic and early postnatal testis development. Endocrinology 1999; 140:2343-2352.
30. Cupp AS, Kim G, Skinner MK. Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, and TGFbeta3) during embryonic rat testis development. Biol Reprod 1999; 60:1304-1313.
31. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377:630-632.
32. Saporta S, Cameron DF, Borlongan CV, Sanberg PR. Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression. Exp Neurol 1997; 146:299-304.
33. Dym M, Fawcett DW. The blood-testis barrier in the rat and the physiological compartmentation of the seminiferous epithelium. Biol Reprod 1970; 3:308-326.
34. Russell L. Movement of spermatocytes from the basal to the adluminal compartment of the rat testis. Am J Anat 1977; 148:313-328.
35. Dufour JM, Rajotte RV, Korbutt GS, Emerich DF. Harnessing the immunomodulatory properties of Sertoli cells to enable xenotransplantation in type I diabetes. Immunol Invest 2003; 32:275-297.
36. O'Rand MG, Romrell LJ. Appearance of cell surface auto- and iso-antigens during spermatogenesis in the rabbit. Dev Biol 1977; 55:347-358.
37. Tung PS, Fritz IB. Specific surface antigens on rat pachytene spermatocytes and successive classes of germinal cells. Dev Biol 1978; 64:297-315.
38. Galili U. Anti-αgalactosyl (anti-gal) antibody damage beyond hyperacute rejection. In: Cooper DKC, Kemp E, Platt JL, White DJG (eds.), Xenotransplantation. The Transplantation of Organs and Tissues Between Species, 2nd ed. Berlin, Germany: Springer; 1997:95-103.
39. Platt JL, Lindman BJ, Chen H, Spitalnik SL, Back FH. Endothelial cell antigens recognized by xenoreactive human natural antibodies. Transplantation 1990; 50:817-822.
40. Griswold MD. The central role of Sertoli cells in spermatogenesis. Semin Cell Dev Biol 1998; 9:411-416.
41. Skinner MK. Cell-cell interactions in the testis. Endocr Rev 1991; 12:45-77.
42. Holers VM, Thurman JM. The alternative pathway of complement in disease: opportunities for therapeutic targeting. Mol Immunol 2004; 41:147-152.
43. Bailey R, Griswold MD. Clusterin in the male reproductive system: localization and possible function. Mol Cell Endocrinol 1999; 151:17-23.
44. Jenne DE, Tschopp J. Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid. Proc Natl Acad Sci U S A 1989; 86:7123-7127.
45. Hochgrebe TT, Humphreys D, Wilson MR, Easterbrook-Smith SB. A reexamination of the role of clusterin as a complement regulator. Exp Cell Res 1999; 249:13-21.
46. Kirszbaum L, Sharpe JA, Murphy B, d'Apice AJ, Classon B, Hudson P, Walker ID. Molecular cloning and characterization of the novel, human complement-associated protein, SP-4040: a link between the complement and reproductive systems. EMBO J 1989; 8:711-718.
47. Bozas SE, Kirszbaum L, Sparrow RL, Walker ID. Several vascular complement inhibitors are present on human sperm. Biol Reprod 1993; 48:503-511.
48. Mead R, Hinchliffe SJ, Morgan BP. Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46). Immunology 1999; 98:137-143.
49. Hinchliffe SJ, Rushmore NK, Hanna SM, Morgan BP. Molecular cloning and functional characterization of the pig analogue of CD59: relevance to xenotransplantation. J Immunol 1998; 160:3924-3932.
50. Maher SE, Pflugh DL, Larsen NJ, Rothschild MF, Bothwell AL. Structure/function characterization of porcine CD59: expression, chromosomal mapping, complement-inhibition, and costimulatory activity. Transplantation 1998; 66:1094-1100.
51. Perez de la Lastra JM, Harris CL, Hinchliffe SJ, Holt DS, Rushmore NK, Morgan BP. Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats. J Immunol 2000; 165:2563-2573.
52. Cervoni F, Oglesby TJ, Adams EM, Milesifluet C, Nickells M, Fenichel P, Atkinson JP, His BL. Identification and characterization of membrane cofactor protein of human spermatozoa. J Immunol 1992; 148:1431-1437.
53. van den Berg CW, Perez de la Lastra JM, Lianes D, Morgan BP. Purification and characterization of the pig analogue of human membrane cofactor protein (CD46/MCP). J Immunol 1997; 158:1703-1709.
54. van den Berg CW, Morgan BP. Complement-inhibiting activities of human CD59 and analogues from rat, sheep, and pig are not homologously restricted. J Immunol 1994; 152:4095-4101.